Director, Breakthrough Lab (B-Lab)
Jason Harry has over 30 years of commercial and academic experience in the medical device field. He is the founder and CEO of Lucidux, an early-stage medical device company developing advanced imaging technologies for minimally invasive surgery. Previously he was founder and CEO of Afferent Corporation, which focused on neurostimulation technologies to treat chronic dysfunction stemming from stroke, aging and diabetes. Prior to founding Afferent, he was VP of Research Engineering at NMT Medical, Inc., Boston, MA, a company in the field of minimally invasive cardiovascular implants. Harry received his PhD in Engineering Science from Harvard University.